Sunshine Biopharma Inc.: Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
Sunshine Biopharma Inc. (NASDAQ:SBFM) said it launched generic amoxicillin in Canada and began shipping to pharmacies this week in multiple dosages and strengths. The company cited 2025 global amoxicillin sales of about $4.9B, projected to reach about $6.4B by 2031. It also noted its Canadian portfolio includes 60 drugs on market.


